About

Director since November 2020. Former Chief Commercial Officer of Kite Pharma and Pharmacyclics; former CEO and board member of CoRegen. Serves on the board of Cabaletta Bio.

Roles

4D Molecular Therapeutics, Inc.
Director · Current role
2020–present

Director Compensation

FY 2025
Fees earned or paid in cash
$62,500
Option awards
$70,000
Total
$132,500

Also at 4D Molecular Therapeutics, Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.